Chicago Equity Partners’s Vericel Corp VCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,590
Closed -$206K 963
2019
Q3
$206K Hold
13,590
0.01% 834
2019
Q2
$257K Hold
13,590
0.01% 826
2019
Q1
$238K Sell
13,590
-50,800
-79% -$929K 0.01% 796
2018
Q4
$1.12M Buy
64,390
+5,908
+10% +$88.4K 0.05% 470
2018
Q3
$828K Buy
58,482
+45,082
+336% +$529K 0.02% 566
2018
Q2
$130K Buy
+13,400
New +$167K ﹤0.01% 804

Other funds holding VCEL

Chicago Equity Partners's VCEL Position: Q4 2019 in Review

Chicago Equity Partners sold out of Vericel Corp (VCEL) in Q4 2019, closing a stake of 13,590 shares — an estimated $206K sold.

Chicago Equity Partners first reported a position in VCEL in Q2 2018 and held it in 6 quarters. The position peaked at $1.12M in Q4 2018. 148 funds tracked by Wall St. Rank hold VCEL as of Q4 2019.

  • Chicago Equity Partners reported no remaining Vericel Corp position as of Q4 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 13,590 Vericel Corp shares in Q4 2019, an estimated $206K.
  • Chicago Equity Partners first reported a position in Vericel Corp in Q2 2018 and held it in 6 quarters.
  • Chicago Equity Partners's Vericel Corp position peaked at $1.12M in Q4 2018.
  • 148 funds tracked by Wall St. Rank held Vericel Corp as of Q4 2019.

Based on Chicago Equity Partners's 13F filing for Q4 2019, filed 10 Feb 2020.